Abstract: A strain sensor may have a conductive elastic yarn including a first fiber having a predetermined length and a shape of a fiber yarn and a second fiber having electrical conductivity and a sheet shape. The strain sensor may have a pair of wiring members electrically connected to both ends of the conductive elastic yarn. The conductive elastic yarn, with the second fiber wrapped around the first fiber, is twisted in a coil shape.

Abstract: The present invention relates to a composition comprising Aster sphathulifolius Maxim extract for preventing, improving, or treating muscular diseases and for improving muscular functions. The Aster sphathulifolius Maxim extract according to the present invention exhibits effects of inhibiting the expression of muscle protein breakdown-related factors and increasing the expression of muscle protein synthesis-related factors, as well as alleviating the reduction of muscle tissue weight and cross-sectional area of muscle fibers, and thus can be useful for preventing, improving, or treating muscular diseases and improving muscular functions.

Abstract: The present invention relates to a pharmaceutical composition for the prevention or treatment of muscle disease comprising a Panax ginseng berry extract as an active ingredient. The composition of the present invention alleviates the decrease in muscle weight and muscle fiber cross-sectional area caused by muscle atrophy, and reduces the increase in expression of MuRF-1 (Muscle RING-finger protein-1) and atrogin-1, which are involved in proteolysis of muscle proteins, so that it can be effectively used to prevent, ameliorate or treat muscle disease.

Abstract: The present invention relates to a composition comprising Aster sphathulifolius Maxim extract for preventing, improving, or treating muscular diseases and for improving muscular functions. The Aster sphathulifolius Maxim extract according to the present invention exhibits effects of inhibiting the expression of muscle protein breakdown-related factors and increasing the expression of muscle protein synthesis-related factors, as well as alleviating the reduction of muscle tissue weight and cross-sectional area of muscle fibers, and thus can be useful for preventing, improving, or treating muscular diseases and improving muscular functions.

Abstract: The present invention relates to a pharmaceutical composition for the prevention or treatment of muscle disease comprising a Panax ginseng berry extract as an active ingredient. The composition of the present invention alleviates the decrease in muscle weight and muscle fiber cross-sectional area caused by muscle atrophy, and reduces the increase in expression of MuRF-1 (Muscle RING-finger protein-1) and atrogin-1, which are involved in proteolysis of muscle proteins, so that it can be effectively used to prevent, ameliorate or treat muscle disease.

Abstract: An input voltage transfer apparatus for an LED lighting system is provided. The input voltage transfer apparatus includes a source voltage storage unit, a zero voltage switching unit, and a nonzero voltage switching unit. The source voltage storage unit stores a source voltage. The zero voltage switching unit turns on according to the source voltage stored in the source voltage storage unit when a zero voltage is inputted. The nonzero voltage switching unit turns on according to a current applied thereto through the zero voltage switching unit when a nonzero voltage is inputted. When the nonzero voltage switching unit is turned on, the source voltage storage unit discharges the stored source voltage.

Abstract: An input voltage transfer apparatus for an LED lighting system is provided. The input voltage transfer apparatus includes a source voltage storage unit, a zero voltage switching unit, and a nonzero voltage switching unit. The source voltage storage unit stores a source voltage. The zero voltage switching unit turns on according to the source voltage stored in the source voltage storage unit when a zero voltage is inputted. The nonzero voltage switching unit turns on according to a current applied thereto through the zero voltage switching unit when a nonzero voltage is inputted. When the nonzero voltage switching unit is turned on, the source voltage storage unit discharges the stored source voltage.

Abstract: A plasma display apparatus and a method of driving the same are disclosed. The plasma display apparatus includes a plasma display panel including a scan electrode, and a scan driver that supplies a setup pulse to the scan electrode. The setup pulse gradually rises to a first voltage level with a first slope, rises from the first voltage level to a second voltage level with a second slope smaller than the first slope, and rises from the second voltage level to a third voltage level with a third slope different from the second slope.